(Press-News.org) Immunothrombosis, or the formation of microscopic blood clots during inflammation, is a major cause of morbidity among patients with sepsis or severe COVID-19. A key enzyme in this process is thrombin. To date, no method exists for early detection of immunothrombosis in a living organism.
A team of investigators led by Ali Hafezi-Moghadam, MD, PhD, director of the Molecular Biomarkers Nano-Imaging Laboratory (MBNI) at Brigham and Women’s Hospital, a founding member of Mass General Brigham healthcare system, and an associate professor of Radiology at Harvard Medical School, developed a novel technology to diagnose immunothrombosis by measuring thrombin activity through breath gas. The researchers generated hyperbranched polymeric nanoprobes, containing thrombin-sensitive regions bound to reporter molecules that would become gaseous upon liberation. Thrombin in microvessels of animals with immunothrombosis liberated the volatile reporter that was then exhaled through the lungs. Gas biopsies, or samples from the exhaled breath, were analyzed in gas chromatography mass spectrometry to deduce the intravascular thrombin activity. These results lay groundwork for clinical translation.
“Early diagnosis of immunothrombosis and intervention could prevent organ failure in patients with sepsis or severe COVID-19,” said Hafezi-Moghadam. “Our technology provides unprecedented knowledge of key enzymatic activity anywhere in the body. Such real-time measurement has the potential to improve personalized and precision treatments and save lives.”
in Advanced Materials.
Funding: This work was supported by NIH Impact Award (DK108238-01), and JDRF Innovation Award (INO-2016-222-A-N).
END
Researchers develop novel technology to quantify protein critical to blood clot formation through breath gas analysis
2023-08-10
ELSE PRESS RELEASES FROM THIS DATE:
C-Path welcomes Sanofi to its Type 1 Diabetes Consortium to help advance drug development
2023-08-10
TUCSON, Ariz., August 9, 2023 — Critical Path Institute (C-Path) announced today that Sanofi, a global leader in immunology and diabetes care, has joined its Type 1 Diabetes Consortium (T1DC). Sanofi joins T1DC as part of its commitment to push the boundaries of innovation to improve the lives of those with diabetes.
T1DC was established in 2017 with the goal to significantly advance the drug development landscape for T1D prevention and treatment. The consortium achieves this by fostering ...
How sure is sure? Incorporating human error into machine learning
2023-08-10
Researchers are developing a way to incorporate one of the most human of characteristics – uncertainty – into machine learning systems.
Human error and uncertainty are concepts that many artificial intelligence systems fail to grasp, particularly in systems where a human provides feedback to a machine learning model. Many of these systems are programmed to assume that humans are always certain and correct, but real-world decision-making includes occasional mistakes and uncertainty.
Researchers from the University of Cambridge, along with The Alan Turing Institute, Princeton, and Google DeepMind, have been attempting ...
Large study suggests people with low levels of vitamin K have less healthy lungs
2023-08-10
People with low levels of vitamin K in their blood are more likely to have poor lung function and to say they suffer with asthma, chronic obstructive pulmonary disease (COPD) and wheezing, according to a study published today (Thursday) in ERJ Open Research [1].
Vitamin K is found in leafy green vegetables, vegetable oils and cereal grains. It plays a role in blood clotting, and so helps the body to heal wounds, but researchers know very little about its role in lung health.
Researchers say their new findings do not alter the current advice on vitamin K intake, but they do support further research to ...
Sanford Burnham Prebys Cancer Center earns merit extension from NCI
2023-08-10
Sanford Burnham Prebys’ Cancer Center has received a rare and prestigious Merit Extension Award from the National Cancer Institute (NCI), recognizing and rewarding its earlier accomplishments as well as current research plans. The award extends the center’s current 5-year Cancer Center Support Grant (CCSG) for an additional two years.
There are only seven Basic Laboratory Cancer Centers in the NCI’s national network. These centers focus primarily on laboratory research: developing, conducting, translating and advancing fundamental discoveries to clinical testing and, ultimately, ...
Stem cell therapy rescues symptoms of Alzheimer’s disease
2023-08-09
In the ongoing search for a cure for Alzheimer’s disease, a burgeoning branch of medicine is bringing new hope. Stem cell therapies are already being used to treat various cancers and disorders of the blood and immune system. In a new proof-of-concept study, scientists at University of California San Diego show stem cell transplants may also be a promising therapeutic against Alzheimer’s.
In the study, publishing this month in Cell Reports, the researchers demonstrate that transplanting hematopoietic ...
Penn Medicine neuroscientists identify brain mechanism that drives focus despite distractions
2023-08-09
PHILADELPHIA—Trying to finish your homework while the big game is on TV? “Visual-movement” neurons in the front of your brain can help you stay focused, according to a new study from neuroscientists in the Perelman School of Medicine at the University of Pennsylvania.
In the study, published recently in Neuron, the scientists sought to illuminate the neural mechanism that helps the brain decide whether to focus visual attention on a rewarding task or an alluring distraction. By analyzing neuron activity in animal models as they faced this kind of attentional ...
Novel machine-learning method produces detailed population trend maps for 550 bird species
2023-08-09
Scientists at the Cornell Lab of Ornithology have developed a novel way to model whether the populations of more than 500 bird species are increasing or decreasing. The method solves a nagging statistical problem by accounting for year-to-year changes in the behavior of people collecting the data. The result is detailed trend maps for each species down to an eight-mile radius--a major boost for local conservation efforts. Scientists used an approach called Double Machine Learning. Details are published in the journal Methods in Ecology and Evolution.
“Changing human behavior presents a problem for statistical analysis ...
CDK9 Inhibitors: A promising combination partner in treating hematological malignancies
2023-08-09
“[...] CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when combined with other therapeutic approaches.”
BUFFALO, NY- August 9, 2023 – A new research perspective was published in Oncotarget's Volume 14 on August 7, 2023, entitled, “CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies.”
In their new perspective, researchers Daniel Morillo, Gala Vega and Victor Moreno from Hospital Fundación Jiménez Díaz discuss Cyclin-dependent ...
A novel theory of aging — independent of damage accumulation
2023-08-09
“We argue that in multicellular organisms, neighbouring cells are in constant competition.”
BUFFALO, NY- August 9, 2023 – A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 14, entitled, “A novel theory of ageing independent of damage accumulation.”
The underlying cause or causes of aging are an enduring mystery, but in 1977 Kirkwood postulated that organisms might gain a fitness advantage by reducing investment in somatic maintenance if this allowed them to invest more resources in more crucial ...
Long-term use of certain acid reflux drugs linked to higher risk of dementia
2023-08-09
MINNEAPOLIS – People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people who do not take these medications, according to new research published in the August 9, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. This study does not prove that acid reflux drugs cause dementia; it only shows an association.
Acid reflux is when stomach acid flows into the esophagus, usually after a meal or when lying down. People with acid reflux may experience heartburn and ulcers. People ...